Skip to main content
Biotest AG logo

Biotest AG — Investor Relations & Filings

Ticker · BIO3 ISIN · DE0005227201 LEI · 529900JVX7RPXBLYUD89 F Manufacturing
Filings indexed 1,148 across all filing types
Latest filing 2024-01-30 Report Publication Anno…
Country DE Germany
Listing F BIO3

Biotest AG is a global company that develops, manufactures, and supplies plasma protein products and biotherapeutic drugs. Sourced from human blood plasma, its products are primarily used in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. The portfolio includes immunoglobulins (e.g., Intratect), coagulation factors, and albumins designed to treat severe and chronic diseases such as immune deficiencies, haemophilia, and coagulation disorders. The company manages the entire value chain from clinical development to sales and is advancing a pipeline of new treatments, including next-generation immunoglobulins (BT595) and fibrinogen concentrates (BT524). Biotest also provides Human Serum Albumin for use as a multifunctional excipient in pharmaceutical and diagnostic applications.

Recent filings

Filing Released Lang Actions
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
Report Publication Announcement Classification · 99% confidence The document text is very short (843 characters) and explicitly functions as a notice. The subject line is 'Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis 30.06.2024' (Notice of Half-Year Financial Report for the period 01.01.2024 to 30.06.2024). It provides a link where the actual report can be found and states the publication date of the notice (30.01.2024). This structure perfectly matches the definition of a Report Publication Announcement (RPA), which announces the availability of a report rather than being the report itself. Since the report covers a half-year period, it is an Interim/Quarterly Report (IR), but this document is the announcement of that report.
2024-01-30 German
Report Publication Announcement 2024
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* and *where* specific financial reports (specifically a 'Financial report of the group (half-year/Q2)') will be disclosed on a future date (July 30, 2024). This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, rather than being the report itself (which would likely be an IR or ER if it contained the actual results). The document length is short (2102 chars), further supporting the RPA classification over a comprehensive report like an IR.
2024-01-22 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
Report Publication Announcement Classification · 100% confidence The document is a short notification (824 characters) informing stakeholders that the 'Halbjahresfinanzbericht' (Interim Financial Report) for the period 01.01.2024 to 30.06.2024 is available on the company's website. It does not contain the report itself, but rather acts as a formal announcement of its publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2024-01-22 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
Report Publication Announcement Classification · 99% confidence The document text is very short (844 characters) and explicitly functions as a notice. It contains the subject line "Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis 30.06.2024" (Notice of Half-Year Financial Report for the period 01.01.2024 to 30.06.2024) and provides a link where the actual report can be found, along with the publication date (30.07.2024). According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the availability of a report falls under Report Publication Announcement (RPA). Although the content relates to an Interim/Quarterly Report (IR), the document itself is the announcement of its publication.
2024-01-22 German
Biotest AG opens 11th plasma collection centre in Germany
Regulatory Filings Classification · 100% confidence The document is a press release dated January 18, 2024, announcing the opening of a new plasma collection center. It uses the EQS-News format, which typically disseminates corporate news. The content is operational/business news ('Miscellaneous' keyword) rather than a formal financial report (like 10-K, IR, ER) or a specific regulatory filing like Director's Dealing (DIRS) or a Dividend Notice (DIV). Since it is a general corporate announcement that doesn't fit the highly specific financial categories, the most appropriate fallback category is Regulatory Filings (RNS), as RNS often serves as a catch-all for material, non-financial regulatory disclosures disseminated via official channels like EQS.
2024-01-18 English
Report Publication Announcement 2024
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* the Annual financial report and Annual financial report of the group for the business year 2023 will be disclosed (March 28, 2024), and provides links to where they will be available. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, rather than being the report itself (like a 10-K or IR). The document length is short (2754 chars), reinforcing the 'announcement' nature based on Rule 2.
2024-01-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.